62. Kalner MA, Storms W, Tilles S, Spector S, Tan R, LaForce C, Lanier BQ, Chipps B. Comparison of olopatadine 0.6% nasal spray versus fluticasone proprionate 50ug in the treatment of seasonal allergic rhinitis patients. Allergy Asthma Proc. 2009 May-June;30(3):255-262. View

61. Chipps B.E. Inhaled corticosteroid therapy for patients with persistent
Asthma: Learnings from studies inhaled budesonide. Allergy Athma Proc. 2009; May-June(3): 217-228. View

60. Murphy, K.R., Zeiger, R.S., Kosinski, M., Chipps, B.E., Mellon, M., Schatz,
M., Lampl, K., Hanlon, J.T., and Ramachandran, S. Test for Respiratory
and Asthma Control in Kids (TRACK): a caregiver-completed questionnaire for preschool-aged children. J Allergy Clin Immunol 2009; 123:833-39. View

59. Miller, DP., Tom, Gladys, Rasouliyan, Lawrence and Chipps, B. Patient-Reported Outcomes among Omalizumab and Salmeterol/Fluticasone Combination Therapy Patients. Journal of Asthma, 46:2,179 — 185 View

58. Haselkorn, T., Fish, J.E., Chipps, B.E., Miller, D.P., Chen, H., and Weiss, S.T. Effect of Weight Change on Asthma-Related Health Outcomes in Patients with Severe or Difficult to Treat Asthma. Respiratory Medicine 2009;103: 274-283. View

57. Chipps, B.E. Zileuton for the Prophylaxis and Chronic Treatment of Asthma. US Respiratory Disease. 2008:15-18. View

56. Spahn, J.D., Stewart, L., Chipps, B.E. How Do You Diagnose Asthma in the Child? Clinical Asthma. 2008;6:57-74. View

55. Chipps, B.E. Asthma in Infants, Children, and Adolescents. Clinical Cornerstone. The Current and Future State of Asthma Treatment. 2008;8:4: 44-58. View

***Updated 1/13/2021***


COVID Vaccine Update

Click Here to learn more

We do not expect to be a site for administration of the COVID19 vaccine.  Please check with your local public health department.

Use this link for more information on the state of California’s tiered system for vaccine administration.


Due to current recommendations made by the US Government/CDC – The Following will go into effect until further notice.

Within the health care community as a whole, there has been an overall increase in the number of patients not seeking necessary medical treatment due to concerns about COVID-19.

If you have a medical problem, please contact your health care provider. It’s important not to delay seeking treatment when you need it.

We are currently open for in-office visits and will continue to offer telemedicine visits moving forward. We understand you might have concerns about coming in to see your health care provider. We want you to know about the steps we are taking to ensure your safety and help prevent the spread of infection:

o Mandatory Masking – All patients and visitors must be masked while in any of our care sites. Please wear a mask or face covering when you enter our facility.

o Limiting Individuals at Appointments – We will limit who is present at a patient visit. Only the patient will be allowed into the facility. If the patient is a minor, only one parent/guardian will be allowed to accompany the patient.

o Temperature Checks – All patients (and parent/guardian if patient is a minor) will have their temperatures checked at the door. Anyone with a temperature of 100 degrees or higher will be asked to reschedule their appointment or conduct the appointment via telemedicine.

o Employee Screening – We’ve instituted mandatory employee temperature screenings before each shift.

New Injection Hours – Effective 7/6/2020

Folsom Office
Monday 8:00-11:45 / 1-4:45
Tuesday Closed
Wednesday 8:00-11:45 / 1-4:45
Thursday 8:00-11:45 / 1-4:45
Friday 8:00-11:45 / 1-4:45

Roseville Office
Monday 9:00-11:45 / 1-4:45
Tuesday 8:00-11:45 / 1-4:45
Wednesday 8:00-11:45 / 1-4:45
Thursday 8:00-11:45 / 1-5:45
Friday 8:00-11:45 / 1-4:45

Monday 9:00-4:45
Tuesday 8:00-5:45
Wednesday 8:00-4:45
Thursday 9:00-4:45
Friday 8:00-4:45